In rats, chronic i.c.v treatment with ghrelin also reveals an increase in anxiety- and depression-like behaviors that are associated with modifications in the expression of key markers involved in these behavioral changes in the amygdala (127). The gene discussed is GHRL; the disease is depressive disorder.